Latest common stock for GNMSF: $10M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (September 2026), GNMSF shows a common stock of $10M. That compares with $10M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, GNMSF's common stock is now $10M (was $10M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Genmab A/S is outperforming or lagging.
Tracking GNMSF's common stock over time shows whether Genmab A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $10M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Genmab A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $10M) with ownership activity and broader fundamentals.
Genmab A/S's common stock is $10M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.